Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 21.36% vs -20.07% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 72.08% vs -11.88% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 67.55% vs -36.61% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -58.62% vs -17.14% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Regeneron Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 21.36% vs -20.07% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 3.62% vs 12.32% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 72.08% vs -11.88% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -2.84% vs 47.90% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 67.55% vs -36.61% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 0.86% vs 8.45% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -58.62% vs -17.14% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -75.68% vs -21.69% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






